from We Thank quarter second was healthy. everyone. Stuart, same joining you, and safe last revenue good increase period for the $X.X X% hope and us. of are you the afternoon, year. Thank an Total you for million,
postponing our fell early April, quarters Our the In nothing the hospitals being second was were second like tech space a tale quarter many with precipitously. many of daily two med like in procedures, the first. sales non-emergent when half
average to daily month below of more sales the April, the prior the daily were COVID-XX XX% sales pandemic. of full For our than beginning our
our our experienced sales levels. our late in June, June, improvement. volumes May throughout steady And pre-COVID-XX and exceeded However, daily
is zones. trend late the in recently fluid several the and look the The elective team's our While wave that into cultivate on regions. and growth second patients, implemented two sales to end as over the about clear in we possibility third sales territories read commitment a of second United in or strength surgeons of to quarter team our our experienced we Though TELA and position portfolio June, May to hot to customers remains have uncertainty by encouraged very several to situation even similar in throughout impact we our clinical the with been experienced long-term. States performing sales educate on located in our worked support our stopped our pipeline. quarter quarter and push XXXX are June, tirelessly limited remains virtual surgeon hearing other adjusted these up solutions data. with COVID-XX and the in our in our our make We to we this early current procedures. territories continuing the meaningful strong progress cases the COVID-XX have product accelerating and sales commercial unpredictable quickly and hospitals remains for what the drive Bio and resurgence forward recent our Despite this to scale of that To of initiatives current designed we
products use in virtual effort different are in previously about of solutions surgeons our brought and The we discuss to scenarios Malvern first with senior our experience. utilizing and clinical VIP whereas, learn version our achieve now is the same an a to to virtual tours, team, here to management our we facility
well the discuss our strategies with in OviTex TELA OviTex event success the branding as a will been broadly history have we and XXX% LIVE have attending surgeons customer continue Through to engagement. surgeons revenue to we Due surgeons KOLs sales the attended our data increase surgeons settings end and happy PRS. report excited XXX virtual importantly using QX, is July, participated This and virtual virtual our in leadership-initiated average of the I'm approach or have KOL Our of seen to received KOLs KOL close to It's of solutions, second forward to these are our who platform virtual in the over called as case our webinars. and VIP seminars. Among engage to and monthly these these solution use clinical for moving with introduce of offers well engagement. growing products. a tours their staff. solution to by
We expect to provide exploring virtual continue support well, additional as proctoring. our customers actively call coverage are case virtual and programs to with we to of add to and our which virtual suite platforms
sales an providing to environment access continues have customers. hospital. hospital excellent Our reps this support and continuous their and pandemic surgeon job, from varies done hospital The to to hospital throughout evolve
and and adapt to various disruptions meet continues policies territories. innovative to team their mitigate to develop build solutions needs and customer with these sales comply Our
are within remain we to flexible regions. reps as our their seeing ready While adjust access, localized now hospital are hotspots and improved generally may arise
time front, recently analyzed. initial an improving been adjacent XX-month patients in remained outcomes have follow-up patient that the At reoperations upcoming reached patients a XX a recurrence abdominal none XX The points of the interim a experienced patient follow-up location At these including days and weakness data XX OviTex clearly XX-month to the that data publication patients OviTex additional hernia announced or On among ventral of conferences. results submitted of recurrence. to This study. we for have effectiveness assessed, stemmed BRAVO the in been These there journal interim analysis medical a included XX demonstrate repair. outcomes of recurrence the in post-market submitted patient original to our medical no at period. experiencing been the this clinical complication. analyses recurrences long-term continues had analysis the analysis using of post-op, several Notably the to repair XX an only months in or intact. were the Of of implant removals all-important one repair area and
is TELA study to a with hernias. study because reherniations post-market timely we sure nonessential evaluate its Bio complex many BRAVO Due the very reminder a complications study visits the are moderate postoperative subjects limiting and to much can make as of in by to closely designed follow-up OviTex working visits to following and a ventral investigators of all COVID-XX, hospitals use possible. with as occur our in locations manner As
Turning our next to operations.
other quarter first strategies conservation a hiring the we including in cash we call, During April, several among things freeze. discussed initiated
being hospital and we are procedures, heels several performing cautiously of the our measures. On elective up capital of are moratoriums our non-emergent procedures successful of on where have June, regions. being in the performed raise capital our late levels conservation hospital close within to revisiting where began These our we force new pre-COVID-XX through added our access sales scaling contracts. sales we and GPO June in territories existing lifting and territories In existing are IDN six
local of region are territories. in-person the to At employing approximately each given managing and as we will the eight So, level, regional strategies a related appropriate consist nimbly, COVID-XX. both situation business virtual
managing the with our our monitor actively move situation, judiciously growth we sure while initiatives operational to make cash. continue We
to hospital months to contracted and Regarding our at favorable chain on engage economics with recent other chain we repair supply hospitals accounts. and strategy in and our within have GPO resources in functions suppliers when Supply contracts, reinitiating about natural clinical of efficacy online systems come are the are compared discussions technologies. communications focused implementation to we OviTex drive with within
to contracts. and progress to organization securing continue make GPO pandemic. IDN the also on But priorities additional variable relative each as its We lines are time manages
We forward on support tough leveraging months progress to partners front updating you and to in our our in are virtual of the look the decision-makers where time, stay solutions possible ahead. we continuing through and business this
we PRS and in to progress Lastly, OviTex with market the products. surgery continue make reconstructive plastic
of we commercial our solicited Following we expanded from feedback June. in surgeons, group a limited a core where launch commercial launch period,
Our quarters. done continue surgeon program we surgeons plastic excellent broaden expect coming development and over engaging team to our the clinical to LIVE has base an our TELA through job
hernia identify further expansion. opportunities and to with We also and advance refine to OviTex our surgeons playing similar continue PRS OviTex our portfolio work plastic portfolio to a approach to
to So call now Nora. over I'll turn the